László Tamás, Kotmayer Lili, Hegyi Lajos, Gróf Stefánia, Kajtár Béla, Balogh Alexandra, . . . et al. (2023). PB1909: Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
Chicago Style (17th ed.) CitationLászló Tamás, et al. PB1909: Low-burden TP53 Mutations Represent Frequent Genetic Events in CLL with an Increased Risk for Treatment Initiation. 2023.
MLA idézésLászló Tamás, et al. PB1909: Low-burden TP53 Mutations Represent Frequent Genetic Events in CLL with an Increased Risk for Treatment Initiation. 2023.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..